IFNAR1 and neoplasm: We therefore reasoned that CAR T cells generated from donor mice which do not express the type I IFN receptor (IFNAR1) would be protected from the deleterious effects induced by VSVmIFNβ, regardless of the level of type IFN in the tumor (Fig. 3g).